Clinical Imaging and Data Resources Core
临床影像和数据资源核心
基本信息
- 批准号:10334984
- 负责人:
- 金额:$ 29.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-02-15 至 2026-12-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAnimal ModelArchivesAwarenessBiological Specimen BanksBiomedical EngineeringBiometryBiostatistics CoreCancer CenterCancer Research ProjectCenters of Research ExcellenceClinicalClinical DataClinical ResearchCollaborationsCommunitiesComputer softwareCost effectiveness researchDataData AnalysesDatabasesDevelopmentEducational workshopEngineeringEnsureEvaluation IndexesFaceFacultyGoalsHealth SciencesHistopathologyImageImaging technologyInfrastructureInstitutional Review BoardsJointsKnowledgeLeadershipLearningLinkMagnetic Resonance ImagingMedical ImagingMedical centerMetadataMethodologyMethodsModelingMonitorOklahomaPathologistPerformancePoliciesProspective StudiesProtocols documentationPublishingRegulationResearchResearch MethodologyResearch PersonnelResearch Project GrantsResearch SupportResourcesRetrospective StudiesSample SizeSamplingSampling StudiesSecureServicesSlideStainsStatistical Data InterpretationStudy modelsTestingThe Cancer Imaging ArchiveTrainingTraining SupportTranslational ResearchTreatment outcomeUnited States National Institutes of HealthUniversitiesValidationVertebratesWritingbiomedical imagingcancer diagnosiscentral databaseclinical biomarkersclinical imagingcollegecost effectivenessdata resourcedesigndigitalexperimental studygraphical user interfacehuman subjecthuman subject protectionimaging biomarkerimaging studyinformatics infrastructuremachine learning methodmachine learning modelmemberoperationperformance testsprogramsquantitative imagingradiological imagingradiologistradiomicsshared databasestatisticssuccesstranslational cancer researchwelfare
项目摘要
ABSTRACT – Clinical Imaging and Data Resources Core
The overarching objective of this Clinical Imaging and Data Resources Core (CIDRC) is to provide research
project leaders (RPLs) of this COBRE with both regulatory and scientific support to facilitate their effort to conduct
medical imaging related translational cancer research projects. The CIDRC will serve as a crucial bridge between
the biomedical imaging research performed in the Gallogly College of Engineering on the University of Oklahoma
(OU) Norman campus and the clinical research community in the Stephenson Cancer Center (SCC) on the OU
Health Science Center (OUHSC) campus. Establishment of a robust, secure and durable mechanism and
platform for storing and sharing images, clinical samples, and associated data is critical to the development and
success of this proposed COBRE. The CIDRC will be organized to ensure the availability of scientifically valid
and well-characterized image data, and the compliance with all NIH regulatory requirements in conducting
human subject and animal model studies, as well as to encourage broad collaborative research efforts between
the biomedical imaging engineering and clinical research. The CIDRC will be established in the SCC of OUHSC
campus because OUHSC provides the broad clinical research service including the Institutional Review Board
(IRB) to examine and approve translational clinical research projects, the biostatistics Core, and services to
retrieve the archived medical images and the H&E stained histopathology slides, and other clinical data of cancer
diagnosis results and treatment outcome. This CIDRC will integrate and strengthen the existing clinical research
supporting resources located on the OUHSC campus to build a new and unique research resource platform to
train and support the RPLs and pilot awardees of this COBRE to conduct joint translational cancer research
projects on two OU campuses. The overall operation of the CIDRC will include to: (1) ensure that RPLs fully
understand all NIH policies and regulations for protection of human subjects and welfare of vertebrate animals,
(2) certify that study protocols for both retrospective and prospective studies are fully compliant with all NIH-
mandated regulatory requirements, (3) assist with the IRB protocol application writing and submission, (4)
provide biostatistics support to confirm that experiments are designed with appropriate sample sizes or statistical
power and the proper statistical data analysis methodologies are used to test and validate the underlying
hypothesis with high scientific rigor, and (5) establish a unique platform that can provide RPLs and other
researchers with the shared databases allowing access to the linked annotated medical images, biospecimens
and clinical data necessary to facilitate their proposed research projects. Thus, the CIDRC will build a critical
scientific and intellectual support infrastructure that aims to ensure the success of this COBRE as the RPLs
make progress in their research projects and transition to the independent researchers in conducting medical
imaging related translational cancer research with the high clinical impact and scientific rigor.
摘要 – 临床影像和数据资源核心
该临床影像和数据资源核心 (CIDRC) 的总体目标是提供研究
该 COBRE 的项目负责人 (RPL) 获得监管和科学支持,以促进他们开展工作
CIDRC 将成为与医学影像相关的转化癌症研究项目之间的重要桥梁。
俄克拉荷马大学加洛格利工程学院进行的生物医学成像研究
(OU) 诺曼校区和 OU 斯蒂芬森癌症中心 (SCC) 的临床研究社区
健康科学中心 (OUHSC) 校园建立健全、安全和持久的机制。
用于存储和共享图像、临床样本和相关数据的平台对于开发和共享至关重要
CIDRC 将组织该提议的 COBRE 的成功,以确保提供科学有效的数据。
和良好表征的图像数据,以及在进行时遵守所有 NIH 监管要求
人类受试者和动物模型研究,以及鼓励之间广泛的合作研究工作
生物医学影像工程和临床研究中心将设立在OUHSC的SCC。
因为 OUHSC 提供广泛的临床研究服务,包括机构审查委员会
(IRB)审查和批准转化临床研究项目、生物统计学核心和服务
检索存档的医学图像和 H&E 染色的组织病理学幻灯片以及其他癌症临床数据
本次CIDRC将整合和加强现有的临床研究。
支持位于 OUHSC 校园的资源,建立一个新的、独特的研究资源平台
培训和支持 RPL 和 COBRE 试点获奖者进行联合转化癌症研究
CIDRC 的总体运作将包括: (1) 确保 RPL 得到充分落实。
了解 NIH 关于保护人类受试者和脊椎动物福利的所有政策和法规,
(2) 证明回顾性和前瞻性研究的研究方案完全符合所有 NIH-
强制性监管要求,(3) 协助 IRB 协议申请的撰写和提交,(4)
提供生物统计学支持,以确认实验设计有适当的样本量或统计数据
使用力量和适当的统计数据分析方法来测试和验证底层
具有高度科学严谨性的假设,以及(5)建立一个独特的平台,可以提供 RPL 和其他
具有共享数据库的研究人员可以访问链接的带注释的医学图像、生物样本
以及促进其拟议研究项目所需的临床数据,因此,CIDRC 将建立一个关键的研究中心。
旨在确保 COBRE 作为 RPL 取得成功的科学和智力支持基础设施
研究项目取得进展,并过渡为从事医学研究的独立研究人员
影像相关的转化癌症研究具有较高的临床影响力和科学严谨性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kathleen N. Moore其他文献
The forefront of ovarian cancer therapy: update on PARP inhibitors.
卵巢癌治疗的前沿:PARP抑制剂的最新进展。
- DOI:
10.1016/j.annonc.2020.06.004 - 发表时间:
2020-06-19 - 期刊:
- 影响因子:0
- 作者:
M. Mirza;R. L. Coleman;A. González;Kathleen N. Moore;N. Colombo;I. Ray;S. Pignata - 通讯作者:
S. Pignata
Effectiveness of cyanoacrylate microbial sealant in the reduction of surgical site infection in gynecologic oncology procedures: A phase III single institution prospective randomized trial.
氰基丙烯酸酯微生物密封剂在减少妇科肿瘤手术中手术部位感染方面的有效性:一项 III 期单一机构前瞻性随机试验。
- DOI:
10.1016/j.ygyno.2016.11.008 - 发表时间:
2024-09-14 - 期刊:
- 影响因子:4.7
- 作者:
Eric D. Thomas;Elizabeth K. Nugent;Matthew C. MacAllister;K. Moxley;L. L;rum;rum;Joan L Walker;D. McMeekin;R. Mannel;G. McGwin;Kathleen N. Moore - 通讯作者:
Kathleen N. Moore
Adolescent Cervical Dysplasia: Histologic Evaluation, Treatment, and Outcomes
青少年宫颈发育不良:组织学评估、治疗和结果
- DOI:
- 发表时间:
2007 - 期刊:
- 影响因子:9.8
- 作者:
Kathleen N. Moore;A. Cofer;Leslie Elliot;G. Lanneau;Joan Walker;Michael A Gold - 通讯作者:
Michael A Gold
OPINION PARP inhibitors in the treatment of ovarian cancer: a review
观点 PARP 抑制剂治疗卵巢癌:综述
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:0
- 作者:
Kathleen N. Moore - 通讯作者:
Kathleen N. Moore
A randomized phase II evaluation of weekly gemcitabine plus pazopanib versus weekly gemcitabine alone in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma.
对每周一次吉西他滨联合帕唑帕尼与每周单独吉西他滨治疗持续性或复发性上皮性卵巢癌、输卵管癌或原发性腹膜癌进行的随机 II 期评估。
- DOI:
10.1016/j.ygyno.2019.10.014 - 发表时间:
2019-12-14 - 期刊:
- 影响因子:4.7
- 作者:
L. Duska;G. Petroni;Nikole Varhegyi;Jubilee Brown;Danijela Jelovac;Kathleen N. Moore;William P. McGuire;C. Darus;L. Barroilhet;A. Secord - 通讯作者:
A. Secord
Kathleen N. Moore的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kathleen N. Moore', 18)}}的其他基金
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
俄克拉荷马州设计和进行 NCTN 临床试验的主要学术参与中心
- 批准号:
10360544 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
俄克拉荷马州设计和进行 NCTN 临床试验的主要学术参与中心
- 批准号:
10582583 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
俄克拉荷马州设计和进行 NCTN 临床试验的主要学术参与中心
- 批准号:
10158024 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials
俄克拉荷马州设计和进行 NCTN 临床试验的主要学术参与中心
- 批准号:
9889077 - 财政年份:2019
- 资助金额:
$ 29.92万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Establishment of a Bat Resource for Infectious Disease Research
建立用于传染病研究的蝙蝠资源
- 批准号:
10495114 - 财政年份:2023
- 资助金额:
$ 29.92万 - 项目类别:
Pathway-guided treatment of immune checkpoint inhibitor therapy-induced colon toxicity
免疫检查点抑制剂治疗引起的结肠毒性的路径引导治疗
- 批准号:
10752985 - 财政年份:2023
- 资助金额:
$ 29.92万 - 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10429403 - 财政年份:2022
- 资助金额:
$ 29.92万 - 项目类别:
Emory/Georgia TB Research Advancement Center (TRAC)
埃默里/佐治亚州结核病研究促进中心 (TRAC)
- 批准号:
10596180 - 财政年份:2022
- 资助金额:
$ 29.92万 - 项目类别: